Determine the necessary mass, volume, or concentration for preparing a solution.
Reslizumab (anti-IL-5) (Ab183026) - ELISA
Immobilized hu-IL-5-His at 2.0 μg/mL can bind Reslizumab (anti-IL-5) (Ab183026) with the EC
₅₀
of 41.32 ng/mL.
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab183026-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $159.90 | |
Ab183026-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $799.90 | |
Ab183026-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,999.90 | |
Ab183026-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $3,199.90 |
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Product Name | Reslizumab (anti-IL-5) - Primary antibody, specific to IL5, Human IgG4 |
---|---|
Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
Specificity | IL5 |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
Action Type | INHIBITOR |
Mechanism of action | INHIBITOR of Interleukin-5 inhibitor |
Product Description | Reslizumab (anti-IL-5) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab (anti-IL-5) is effective in neutralizing the function of IL-5. Reslizumab (anti-IL-5) has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively. |
Isotype | Human IgG4 |
---|---|
Light Chain Type | kappa |
Purification Method | Protein A purified |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 241473-69-8 |
Reslizumab (anti-IL-5) (Ab183026) - ELISA
Immobilized hu-IL-5-His at 2.0 μg/mL can bind Reslizumab (anti-IL-5) (Ab183026) with the EC
₅₀
of 41.32 ng/mL.
Reslizumab (anti-IL-5) (Ab183026) - SEC
The purity of Reslizumab (anti-IL-5) (Ab183026) is more than 95% verified by HPLC.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0708696 | Certificate of Analysis | Jul 24, 2024 | Ab183026 |
ZJ24F0708695 | Certificate of Analysis | Jul 24, 2024 | Ab183026 |
ZJ24F0708694 | Certificate of Analysis | Jul 24, 2024 | Ab183026 |